Publications
- TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer2019 | Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients2018 | Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Trial Watch Dendritic cell-based interventions for cancer therapy2013 | Second Faculty of Medicine
- Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials2011 | Second Faculty of Medicine
- Imunogenic cell death and it ´s application in immunotherapy protocolsPublication without faculty affiliation
- Type I interferon and cancer2024 | Second Faculty of Medicine
- Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients2023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma2023 | First Faculty of Medicine, Second Faculty of Medicine
- Trial watch: chemotherapy-induced immunogenic cell death in oncology2023 | Second Faculty of Medicine
- Interferon signaling restrains renal cell carcinoma heterogeneity2023 | Second Faculty of Medicine
Loading network view...